Botanical species · safety record

Apocynum androsaemifolium

The EFSA Compendium of Botanicals holds 10 constituent measurements for Apocynum androsaemifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Apocynum androsaemifolium L.

10Constituent measurements
0Safety records
1Cited sources
6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Apocynum androsaemifolium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Root

What the records describe

Constituents measured

  • Cardenolides6
  • Cardenolide glycosides2
  • Cymarin2

Plant parts

  • Roots and other underground parts10

Preparations

  • Solvent extraction10

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Cardenolide glycosidesRoots and other underground partsSolvent extraction≥ 0.056 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Cardenolide glycosidesRoots and other underground partsSolvent extraction≤ 0.537 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≤ 0.048 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≤ 0.25 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≥ 0.027 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≤ 0.122 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≥ 0.026 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CardenolidesRoots and other underground partsSolvent extraction≥ 0.045 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CymarinRoots and other underground partsSolvent extraction≤ 0.19 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CymarinRoots and other underground partsSolvent extraction≥ 0.007 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Genkina, G. L., Khodzhaev, K. Kh., Shakirov, T. T., Abubakirov, N. K. Roots of Apocynum androsaemifolium and Apocynum cannabinum studied for cardenolide content. Khimiya prirodnykh soedinenii, 1972, vol. (3), p. 321-4.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue